Summary
The action of β-bungarotoxin (β-BuTX) on spontaneous transmitter release, as monitored by miniature endplate potential (MEPP) frequency, and nerve-stimulated release, which relates directly to endplate potential (EPP) amplitude, was studied at frog sciatic nerve-sartorius muscle junctions. Three phases were found for both spontaneous and evoked release: a transient decrease followed by an increase and a later decrease leading to complete failure. The initial inhibitory phase for both spontaneous and neurally-evoked release occurred at the same time and was independent of stimulation frequency. Both the excitatory and late inhibitory phases for both types of release had a more rapid onset when stimulation frequency was increased, with the effects on evoked release occurring more rapidly than the effects on spontaneous release. Even though EPP amplitude decreased to low levels while MEPP frequency was still high, EPPs did not completely fail until the MEPPs had also declined to very low levels. In elevated K+ solutions, the number of quanta released after toxin application was only about half that released during the control experiment. During the terminal part of the late inhibitory phase of β-BuTX action on MEPP frequency, no effect or only small transient increases were observed after La3+ administration, elevated [K+]0, or increased osmotic pressure. The present study suggests that depolarization of nerve terminals by the toxin is responsible for initiation of the excitatory phases of both types of release followed by inhibition of nerve-evoked release, and then depletion of vesicular transmitter accounts for the eventual disappearance of both MEPPs and EPPs.
Similar content being viewed by others
References
Abe T, Alemà S, Miledi R (1977) Isolation and characterization of presynaptically acting neurotoxins from the venom of Bungarus snakes. Eur J Biochem 80:1–12
Abe T, Limbrick AR, Miledi R (1976) Acute muscle denervation induced by β-bungarotoxin. Proc R Soc Lond Ser B Biol Sci 194:545–553
Alderdice MT (1979) Physostigmine, but not neostigmine, inhibits acetylcholine release. Brain Res 178:596–599
Alderdice MT, Volle RL (1978) The increase in spontaneous transmitter release produced by β-bungarotoxin and its modification by inorganic ions. J Pharmacol Exp Ther 205:58–68
Castillo J del, Katz B (1954) Quantal components of the end-plate potential. J Physiol (Lond) 124:560–573
Chang CC, Chen TF, Lee CY (1973) Studies of the presynaptic effect of β-bungarotoxin on neuromuscular transmission. J Pharmacol Exp Ther 184:438–444
Chen I, Lee CY (1970) Ultrastructural changes in the motor nerve terminals caused by β-bungarotoxin. Virchows Arch (Cell Pathol) 6:318–325
Conway EJ (1957) Nature and significance of concentration relations of potassium and sodium ions in skeletal muscle. Physiol Rev 37:84–132
Cooke JD, Quastel DMJ (1973) The specific effect of potassium on transmitter release by motor nerve terminals and its inhibition by calcium. J Physiol (Lond) 228:435–458
Elmqvist D, Quastel DMJ (1965) Presynaptic action of hemicholinium at the neuromuscular junction. J Physiol (Lond) 177:463–482
Howard BD (1975) Effects of β-bungarotoxin on mitochondrial respiration are caused by associated phospholipase A activity. Biochem Biophys Res Comm 67:58–65
Howard BD, Gundersen Jr, CB (1980) Effects and mechanisms of polypeptide neurotoxins that act presynaptically. Ann Rev Pharmacol Toxicol 20:307–336
Katz B, Thesleff S (1957) On the factors which determine the amplitude of the ‘miniature end-plate potential’. J Physiol (Lond) 137:267–278
Kelly RB, Brown FR (1974) Biochemical and physiological properties of a purified snake venom neurotoxin which acts presynaptically. J Neurobiol 5:135–150
Kelly RB, Oberg SC, Strong PN, Wagner GM (1975) β-Bungarotoxin, a phospholipase that stimulates transmitter release. Cold Spring Harbor Symp Quant Biol 40:117–125
Kelly RB, Wedel RJ von, Strong PN (1979) Phospholipase-dependent and phospholipase-independent inhibition of transmitter release by β-bungarotoxin. In: Ceccarelli B, Clementi F (eds) Advances in cytopharmacology, vol. 3 Raven Press, New York, p 77
Lee CY, Chang CC (1966) Modes of actions of purified toxins from elapid venoms on neuromuscular transmission. Mem Inst Butantan Simp Internact 33:555–572
Livengood DR, Manalis RS, Donlon MA, Masukawa LM, Tobias GS, Shain W (1978) Blockade of neuromuscular transmission by enzymatically active and inactive β-bungarotoxin. Proc Natl Acad Sci USA 75:1029–1033
Martin AR (1955) A further study of the statistical composition of the endplate potential. J Physiol (Lond) 130:114–122
Oberg SG, Kelly RB (1976) The mechanism of β-bungarotoxin action. I. Modification of transmitter release at the neuromuscular junction. J Neurobiol 7:129–141
Sen I, Grantham PA, Cooper JR (1976) Mechanism of action of β-bungarotoxin on synaptosomal preparations. Proc Natl Acad Sci USA 73:2664–2668
Strong PN, Goerke J, Oberg SG, Kelly RB (1976) β-Bungarotoxin, a presynaptic toxin with enzymatic activity. Proc Natl Acad Sci USA 73:178–182
Wagner GM, Mart PE, Kelly PB (1974) β-Bungarotoxin inhibition of calcium accumulation by rat brain mitochondria. Biochem Biophys Res Commun 58:475–481
Wernicke JF, Vanker AD, Howard BD (1975) The mechanism of action of β-bungarotoxin. J Neurochem 25:483–496
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Alderdice, M.T., Volle, R.L. Multiple actions of β-bungarotoxin on acetylcholine release at amphibian motor nerve terminals. Naunyn-Schmiedeberg's Arch. Pharmacol. 316, 126–130 (1981). https://doi.org/10.1007/BF00505305
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00505305